Madero L, Muñoz A, Lorenzo G, Amaya J, Alonso M A, Durán R
Servicio de Pediatría, Hospital Ramón y Cajal, Madrid.
Med Clin (Barc). 1990 Oct 20;95(13):486-9.
We evaluated 27 patients with localized Ewing's sarcoma diagnosed in our hospital. In 9 cases the lesion was centroaxial and in 18 it was located in the limbs. The treatment consisted of: 1) chemotherapy with 6 drugs (vincristine, cyclophosphamide, methotrexate, bleomycin, actinomycin D and adriamycin) during one year in all patients, and 2) radiotherapy in 24 patients with a dose of 30-40 Gy in the involved bone with a 10-15 Gy superimpression on the tumor area. In 7 patients nonradical surgery followed by radiotherapy was carried out. In 2 cases with rib localization and in 1 with tibial localization and large bone destruction radical surgery was undertaken. One patient had a local relapse (femur) and six had distant metastases. The remaining 20 patients (74%) are alive and without evidence of disease, with follow-up periods ranging from 17 to 80 months (median 38 months). The estimated actuarial free from disease survival was 64% after 58 months. Sequelae of therapy were evaluated in the 12 survivors with primary localization in the limbs. In 7 cases (58%) there were minimal sequelae, in two moderate and in three there was a severe limitation, but amputation was not required in any patient. The results of our study show that the local control of the disease can be achieved in most cases without radical surgery and with an acceptable limb function.
我们评估了我院诊断的27例局限性尤因肉瘤患者。9例病变位于中心轴,18例位于四肢。治疗包括:1)所有患者均接受为期一年的6种药物化疗(长春新碱、环磷酰胺、甲氨蝶呤、博来霉素、放线菌素D和阿霉素);2)24例患者接受放疗,受累骨的放疗剂量为30 - 40 Gy,肿瘤区域追加10 - 15 Gy。7例患者接受了非根治性手术,术后进行放疗。2例肋骨部位及1例胫骨部位且有大块骨破坏的患者接受了根治性手术。1例患者出现局部复发(股骨),6例出现远处转移。其余20例患者(74%)存活且无疾病证据,随访时间为17至80个月(中位时间38个月)。58个月时预计的无病生存率为64%。对12例原发于四肢的存活患者的治疗后遗症进行了评估。7例(58%)有轻微后遗症,2例中度后遗症,3例有严重功能受限,但无一例患者需要截肢。我们的研究结果表明,在大多数情况下,无需进行根治性手术且肢体功能可接受的情况下,可实现疾病的局部控制。